All posts by medical

Inflammation produced by bacterial infection ‘alerts’ the brain stem cells – News-Medical.net

The study, directed by Isabel Farias and published in the November digital edition of the journal Cell Stem Cell, reveals that the inflammation produced by a bacterial infection 'alerts' the brain stem cells and prepares their activation for the production of new neurons. The study represents a new advance in the field of regenerative medicine.

The team of researchers from the Molecular Neurobiology group of the University of Valencia, led by the professor of Cell Biology Isabel Farias, has just published in the journal Cell Stem Cell the results of a work that sheds light on the role of inflammation in the normal programming of adult brain stem cell activation to produce new neurons throughout life.

Our tissues are constantly renewed thanks to stem cells, which generate new specialized cells to replace those that are lost through "wear and tear". These stem cells are located in very specific locations within tissues, which are known as microenvironments or niches, and in which stem cells interact with other types of cells.

The new findings indicate that brain stem cells also respond to changes that occur outside the brain. This study, carried out in mice, has verified that the inflammation produced by a bacterial infection in any part of the body is capable of temporarily activating brain stem cells and preparing them for action. When the inflammation subsides, these cells return to their quiescent state.

The work allows us to better understand the relationships between stem cells and the systemic environment, that is, the rest of the organism, as knowledge on the subject is very limited. We are used to stem cells responding to their closest microenvironment, but evidence is beginning to emerge showing that they can respond to what is happening in any part of the body thanks to molecules that are distributed through the circulatory system."

Isabel Farias, Professor of Cell Biology, University of Valencia

The work of the research team contributes, once again, new data to the study and advancement of regenerative medicine, a field of science that seeks therapeutic solutions based on stem cells for degenerative processes, such as Alzheimer's or Parkinson's diseases in which neuroinflammation is usually detected.

"We have always been more concerned about chronic inflammation that is associated with many diseases and is very negative for our organs, but it is a defence mechanism against damage or infection", explains Jos Manuel Morante, co-director of the work. "For this reason, it is important to find out the role of inflammation in the regulation of stem cells", he concludes.

Several doctors from the University of Valencia (Germn Belenguer, Ana Domingo, Toni Jordn, Sacri R. Ferrn and Jos Manuel Morante) and researchers in training Pere Duart and Laura Blasco have participated in the research. Farias' team belongs to the Molecular Neurobiology group of the Institute of Biotechnology and Biomedicine of the same University, the Centre for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) and the RETIC of Cell Therapy of the Carlos III Health Institute, and is a Prometheus group of excellence of the Valencian Government.

Source:

Journal reference:

Belenguer, G., et al. (2020) Adult Neural Stem Cells Are Alerted by Systemic Inflammation through TNF- Receptor Signaling. Cell Stem Cell. doi.org/10.1016/j.stem.2020.10.016.

Go here to see the original:
Inflammation produced by bacterial infection 'alerts' the brain stem cells - News-Medical.net

MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution – Newswise

Newswise MURFREESBORO, Tenn. A first-of-its-kind study led by Middle Tennessee State University biology researcher Elizabeth Barnes suggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology.

Barnes and Arizona State University researchers asked whether Black and Hispanic students tended to reject evolution more than students from other racial/ethnic identities and whether any differences could be explained by the fact they tend to be more religious.

The study, published Friday, Nov. 20, by CBE Life Sciences Educations quarterly journal, can be found here.

Christianity is popular among 65% of college biology students, but not among the biologists (25%) who are teaching students, which helped the research group understand the motivation for the study.

Further, when looking at students from minority populations, the gap between biologists and student religious affiliation is even wider Black students tend to have stronger religious cultures and backgrounds compared to majority populations.

Researchers found that rejection of evolution was particularly high for Black students, but once they controlled for religious background in their statistical models, the differences between Black and white students were diminished.

This is a concerning finding for STEM (science, technology, engineering and math) educators because Black students are already minoritized in biology and they are particularly absent in fields that emphasize evolution such as ecology and evolutionary biology, said Barnes, who joined the MTSU faculty in August. Our study starts to offer some explanation for why.

Researchers suggest that a solution is to use instructional techniques that highlight the compatibility between religion and evolution rather than where they might conflict.

Science instructors who are often secular themselves are hesitant to address religion and when they do it is often in a way that highlights conflict between religion and science and not compatibility, Barnes said.

To promote an equitable and comfortable STEM environment for religious students, science instructors should more often highlight views such as theistic evolution, for which student can both believe in God and recognize evolution as credible science, she added.

Barnes was joined in the research by K. Supriya, Hayley M. Dunlop, Taija M. Hendrix, Gale M. Sinatra and Sara E. Brownell. They began collecting data five years ago.

We collected a lot of data and spent a lot of time revising the work based on feedback and reading about the experiences of Black and Hispanic individuals, Barnes said.

Barnes labs website can be found here.

CBE Life Sciences Education is a free, online quarterly journal published by the American Society of Cell Biology. It publishes peer-reviewed articles on life science education at the K-12, undergraduate and graduate levels.

About Liz Barnes

Assistant professor Elizabeth Barnesis an MTSU science education researcher. She studies the intersections of science and religion, how individuals perceive the relationship between science and religion and how science educators can foster productive conversations with communities and students of faith to promote science education.

Coming from Arizona State University, where she earned bachelors, masters and doctoral degrees, and was a National Science Foundation Graduate Research Fellow, Barnes arrived with grants to continue her research at MTSU.

I came to MTSU to study how to effectively teach controversial topics in biology to students across different religious and political spectrums, she said. I was lured to MTSU because of the Mathematics and Science Education Ph.D. program, which will allow me to mentor graduate students and build a robust research program.

On deck: My past and current research focus is on perceptions of evolution and I have studied how to make evolution education more inclusive for students from different religious and racial/ethnic backgrounds, she said. I am now excited to be embarking on projects exploring perceptions of climate change, vaccines and COVID19.

Originally posted here:
MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution - Newswise

Researcher Examining CBD Effects on Metabolic Syndrome | Newsroom – UC Merced University News

About 35 percent of Americans have metabolic syndrome, a group of risk factors that raises the risk of cardiovascular disease the leading cause of death in the United States.

If you have three of these five issues, you have metabolic syndrome, according to the American Heart Association:

Department of Molecular and Cell Biology Chair and Health Sciences Research Institute memberProfessor Rudy Ortiz is launching a new project to find out if cannabidiol (CBD), either derived from hemp or synthesized in the lab, can have positive effects on issues within metabolic syndrome.

Ortiz will receive $300,000 over the next two years from the Center for Medical Cannabis Research (CMCR) at UC San Diego to see whether CBD can ameliorate hypertension and glucose intolerance in models of metabolic syndrome.

There have been two different studies showing two different results, so we dont know what the truth is, Ortiz said. No study has looked at this directly in a controlled setting, so our data is applicable no matter what it shows.

Professor Anna Song, director of the Nicotine and Cannabis Policy Center at UC Merced, agreed.

Professor Ortizs study will be an important contribution. Our communities are barraged with messages regarding the benefits of CBD and cannabis, but the science isnt just there yet, Song said. This study will be extremely helpful in shedding some light on where CBD is helpful and where it might not help at all.

This pilot study is one important step on the path to human trials if the results are positive.

We need to keep our minds open about what plant-based compounds of any kind can offer, Ortiz said. There has been so much stigma around cannabis, but its becoming more accepted, especially its medicinal benefits.

Heart disease and Type 2 diabetes are primary outcomes of metabolic syndrome, and high blood pressure can lead to stroke, heart attack, vision loss and kidney disease.

Professor Ortizs work exemplifies UC Merceds leadership in using science to explore creative solutions to medical problems that affect millions of Americans, School of Natural Sciences Dean Betsy Dumont said. The potential of this work to identify effective, low-cost treatments that could be made widely available is exciting.

Go here to read the rest:
Researcher Examining CBD Effects on Metabolic Syndrome | Newsroom - UC Merced University News

Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes – India Education Diary

Ottawa: There are more than 300,000 Canadians living with type 1 diabetes (T1D), an autoimmune disease with no known cause or cure, resulting in the dysfunction, damage or loss of pancreatic beta cells that produce insulin in our bodies. People with T1D must treat themselves with insulin several times per day to keep their blood glucose levels normal, and despite their best efforts, they often experience serious, and even life-threatening, complications.

To mark the end of Diabetes Awareness Month, Sonia Sidhu, Member of Parliament for Brampton South, on behalf of the Honourable Patty Hajdu, Minister of Health, announced an investment of $6 million through the CIHR-JDRF Partnership to Defeat Diabetes for two Canadian research teams to accelerate the development of stem cell-based therapies for the treatment of T1D.

Stem cells show great promise as a source of insulin-producing cells that could be transplanted to provide a new source of insulin, to replace dysfunctional, damaged or lost pancreatic beta cells. Canada has a remarkable legacy in leading discoveries in this area. Stem cells were discovered in Toronto in 1961, and in 2000, a team in Edmonton were the first to pioneer transplantation of pancreatic islets (the part of the pancreas that contains insulin-producing cells). These achievements represent important steps toward a treatment that will allow people with T1D to live healthy lives without daily insulin injections.

The research teams are led by Dr. Maria Cristina Nostro at the University Health Network and the University of Toronto and Dr. Francis Lynn at the BC Childrens Hospital Research Institute and the University of British Columbia. The teams will build on Canadas demonstrated research excellence and leadership in clinical islet transplantation, stem cell biology, diabetes, immunology and genetic engineering to accelerate stem cell-based therapies for T1D. They will work in collaboration with other Canadian researchers to tackle some of the biggest scientific challenges that impede our progress in this area and move us closer to a future where people with T1D will no longer rely on insulin therapy.

This funding was provided by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD), and JDRF Canada, through the CIHR-JDRF Partnership to Defeat Diabetes established in 2017. Each partner will invest $3 million over five years. This investment is part of a large research initiative, 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, funded by CIHR and partners. This initiative commemorates the 100th anniversary of the discovery of insulin to be marked in 2021a discovery that changed the lives of millions of Canadians and people around the world and won researchers Sir Frederick Banting and John Macleod the Nobel Prize in Physiology or Medicine.

More here:
Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - India Education Diary

What are chemical signs of life beyond Earth? – Chemical & Engineering News

In brief

When astrobiologists look for physical evidence of past or present life beyond Earth, they search for biosignatures, like molecules with chemistry that doesnt make sense on the basis of nonliving processes. But determining if a molecule from another world is out of place enough to come from life means that scientists first have to understand the nonliving chemistry of the planetary body where it was found. While some scientists are developing tools like the Ladder of Life Detection to effectively evaluate biosignatures, others are trying to figure out how to differentiate biological chemistry from the rest. This conceptual work could help scientists who are analyzing data collected by missions searching for life in our solar system or beyond.

In 1976, two probes from NASA landed on Mars to conduct the first experiments in search of life beyond Earth.

The Viking 1 and 2 landers were looking for evidence of living martian microbes. They treated soil samples with nutrients or other compounds that microbes could metabolize and then monitored for molecules that indicated active biochemistry.

Initial results had scientists excited: one experiment detected radiolabeled gases emitted from samples treated with carbon-14-labeled nutrients. If information from other experiments on board the two Viking landers had not been available, this set of data would almost certainly have been interpreted as presumptive evidence for biology, writes Harold Klein, a NASA astrobiologist involved with the original Viking missions, in a paper published about the results (Icarus 1978, DOI: 10.1016/0019-1035(78)90053-2).

But other instruments on the Viking landers detected only trace amounts of organic moleculeslike chloro- and dichloromethane. The lack of complex molcules, organic or otherwise, precluded a biological explanation for the radiolabeling results. Other experiments run by the landers were inconclusive at best. After many years of intense debate, the scientific community eventually concluded that nonliving, or abiotic, processeslike unknown oxidants in the soilwere a more likely explanation for the Viking results.

These experimental results demonstrated just how challenging it can be to identify physical signs of life, or biosignatures, much less make a definitive claim for having found life on another planet. The Viking missions led scientists to develop new techniques for evaluating biosignatures and instrumentation for detecting them. But these initial experiments also caused scientists to ask: How do we determine if something is alive in the first place?

Credit: NASA/JPL

This photo of the martian landscape was taken by the Viking 1 lander on July 23, 1976.

By and large, what we do in biosignature science is chemistry, says Heather Graham, an organic geochemist at the Catholic University of America and NASAs Goddard Space Flight Center. Biosignatures can be fossilized cells or active microbial communities. But they can also be molecules that are made only by living organisms. These biosignatures are molecules that would be out of place in a planets geochemistry if it were not for some living organism churning them out.

By and large, what we do in biosignature science is chemistry.

Heather Graham, organic geochemist, Catholic University of America and NASAs Goddard Space Flight Center

Yet without understanding the fundamental chemistry of our universe, scientists cant determine whether a physical indicator is weird enough to come from life. Now, scientists are trying to figure out what distinguishes biological chemistry from other types of chemistry and how we can quantifiably detect it. This work includes reevaluating what chemists have assumed about how biochemistry evolved on Earth. Astrobiologists hope this fundamental chemical research will help researchers collect and assess data from within our solar system and beyond.

Ladder of life

Before scientists can start to look for molecular signs of life, they need to define what life is. NASAs working definition is a self-sustaining chemical system capable of Darwinian evolution. NASA scientists see life as a system of molecules that can reproduce, store information, and generate energy through metabolizing molecules in its environment.

NASA researchers have used that definition to establish a system for assessing whether a molecule or material from outer spaceor even ancient Earthis a biosignature. They call this framework the Ladder of Life Detection (Astrobiology 2018, DOI: 10.1089/ast.2017.1773). Developed by a research team led by Marc Neveu, an astrobiologist with the University of Maryland, College Park, and the Goddard Space Flight Center, the ladder consists of rungs corresponding to key features that scientists might look for in life, going from ones that are not strongly indicative of life to those that are.

The key starting point here is that life has many features, but no single feature is a telltale sign of life in and of itself, Neveu says. He thinks the ladder can help scientists think about how to compile a chain of evidence in a practical way.

For example, amino acids are the building blocks of proteins on Earth. If scientists found these molecules on another planet, that would correspond to the rung for potential biomolecule components. But thats only if amino acids cant be produced by any nonliving systems on that planet. A chemical hint of life can be deemed a biosignature only if the compound deviates from abiotic distributions, the authors write, meaning its presence or abundance doesnt make sense given the planets general geochemistry.

Ladder of Life Detection

This framework helps scientists build a chain of evidence to confirm a potential observation of life. Features on the rungs ascend from weakly (bottom) to strongly (top) suggesting a living organism has been observed. Scientists would need to find features from multiple, but not all, rungs to claim that life has been found.

Credit: Adapted from Astrobiology/C&EN/Shutterstock

Top rung: Darwinian evolution

Cultured microbes that show signs of adaptation to selective pressure would be a strong biosignature of life. These features are impractical to detect in current missions in our solar system.

Growth and reproduction

Observation of a suspected microbe at multiple stages of its life cycle would be needed to confirm growth and reproduction. Microbe motility could also indicate life on this rung.

Metabolism

Metabolic cycles can extract energy from molecules in the environment. These cycles often show a preference for certain isotopes or molecules, which change their abundance in biomass compared with the nonliving environment.

Functional molecules and structures

This class of molecules includes polymers with repeating charges or structures that might support information storage or other biological functions.

Potential biomolecule components

This category includes the smaller building blocks that could make up complex biomoleculeslike the amino acids that build proteins on Earth. Some of these monomers are not produced abiotically on Earth.

Potential metabolic by-products

These complex molecules accumu- late in a distinct way in the environ- ment or contain features that follow a pattern, suggesting a living metabolic cycle is at play. These featuressuch as the carbon accumulated in a desert shrubare more generic than those of the metabolism rung.

Bottom rung: Biofabrics

Credit: Adapted from Astrobiology/C&EN/Shutterstock

Biofabrics are structures, like mats or layered morphologies, created by microbial colonies. They can be living or fossilized and can be observed with microscopy.

It really puts a lot of the burden of proof that you found life on understanding the context of what your environment looks like and what abiotic processes that dont involve life are at play, Neveu says. The key here is to understand where the baseline is. Even if scientists can be reasonably sure that theyve detected a potential biosignature, the ladder says that life has to be the hypothesis of last resort.

Frances Westall, a geologist with Frances National Center for Scientific Research and a scientist with the European Space Agency (ESA), says the ladders usefulness can be demonstrated by applying the framework to results from past experiments.

For example, when reevaluating the Viking experiments, scientists today would place the detection of those radiolabeled gases on the rung for metabolism because the gases suggested a response to the addition of possible metabolic fuels. But the Viking experiments produced no other data that could go on the ladder. Even after scientists confirmed that the signals detected by the Viking landers instruments are real, the biosignatures fail to rule out enough abiotic processes to claim life as a last-resort hypothesis. Researchers can thus conclude that there certainly is evidence for life, just not sufficient evidence to exclude abiotic processes, Neveu says.

The key starting point here is that life has many features, but no single feature is a telltale sign of life in and of itself.

Marc Neveu, astrobiologist, University of Maryland, College Park, and NASAs Goddard Space Flight Center

Its not that an experiment should be expected to find a feature on every rung of the ladder, Neveu says, but one feature is not enough to claim that youve found an alien life-form. Neveu hopes that the ladder will help scientists designing missions in search of life think about what kinds of evidence they would need to build a case for life.

The Ladder of Life Detection is still a work in progress and is meant to spur further discussion in the astrobiology community, Neveu says. One major limitation is that the ladder centers on NASAs working definition of life. It all depends on what definition of life youre starting from, Neveu says, and thats definitely an issue that has not been resolved. The order of rungs is also up for debate. Neveu expects that scientists will continue to add features and criteria to the ladder as our understanding of chemical traces of life evolves.

The future of Mars

Despite the disappointing results from the Viking missions, Mars remains a favorite destination for astrobiologists. Though the Red Planets climate is harsh and its surface is bombarded with biology-zapping ultraviolet radiation, planetary scientists believe that Mars may have once looked a lot like Earth, coursing with rivers that could have been home to microbes.

The ESA and Russias Roscosmos are jointly planning a mission called ExoMars 2022 that will explore Oxia Planum, a region of Mars rich in clay deposits that may have been left behind by an ancient river delta. The rover, named Rosalind Franklin, is specially equipped to look for signs of past and present life.

Because the martian surface is a harsh environment for preserving organic molecules, the Rosalind Franklin will drill down 2 m below the surface to collect samples that have been protected from the elements. A suite of onboard instrumentation, including the Mars Organic Molecule Analyzer (MOMA), will then interrogate the collected samples.

The samples can be processed one of two ways. In one, a sample is heated in an oven where volatile molecules are separated by gas chromatography before entering the ion-detection trap of MOMAs mass spectrometer. This process is not ideal for large organic molecules that might break apart with heat, so MOMA also has a laser to vaporize soil samples and directly inject the released molecules into the mass spectrometer.

Credit: ESA/ATG Medialab

The Rosalind Franklin rover will search for life on Mars as part of the ExoMars 2022 mission.

Fred Goesmann, the principal investigator for MOMA and a scientist at the Max Planck Institute for Solar System Research, says the different sample preparation platforms allow MOMA to detect a broad array of organic molecules. So the researchers can start with very few assumptions on what we might encounter, Goesmann says.

Unlike the Viking experiments, the MOMA instruments arent trying to elicit a response from samples that could indicate ongoing biochemistry. Instead, the equipment is designed to look for inherent features of organic molecules that could suggest they came from living systems.

Goesmann says that when scientists look for such features, the underlying assumption is that life creates order. He says that life is choosy, meaning it prefers some molecules over others, so its presence can change the distribution of chemical species on a planet. For example, organisms on Earth prefer lighter isotopes in biomolecules, so the amount of carbon-13 and carbon-14 in organisms differs from their relative abundances on the planet in general. Such isotopic fractionation is a feature of metabolism on the Ladder of Life Detection and can easily be probed with a mass spectrometer.

Another feature of Earths biochemistry, which is also found on the ladders rungs, is a preference for chiral molecules. Most sugars and amino acids used in biology are exclusively one enantiomer, for example. Goesmanns MOMA instruments will be the first to directly analyze the chirality of organic molecules on another world. Because chiral molecules are difficult to characterize with gas chromatography/mass spectrometry, MOMA contains a tiny wet lab to modify the chiral molecules in a way that makes them distinguishable from one another and detectable in the mass spectrometer. Complex organic molecules featuring isotopic fractionation or an excess of one enantiomer could be important results for building a chain of evidence in favor of life on Mars.

In the meantime, the Perseverance rover, part of NASAs Mars 2020 mission, is equipped to prepare samples that may one day return to Earth for thorough analysis in traditional wet labs. The mission launched this summer and is scheduled to land in February 2021 at Jezero Crater, where the rover will also conduct experiments on the planet itself.

Back to the drawing board

But even as missions in search of life are planned for Mars and other bodies in our solar system, chemists on Earth continue to debate the basic molecular signs of life.

I think the assumption within the prebiotic chemistry community and much of the biological community is that metabolism is a result of evolution, says Joseph Moran, an organic chemist at the University of Strasbourg. According to this prevailing view, molecules like enzymes evolved before the metabolic cycles they perform inside cells to produce energy and build cellular components. Moran takes the opposite view. His research with enzyme-free catalysis suggests that many biochemical reactions on Earth were possible under prebiotic conditionsbefore life was present.

Credit: Adapted from Nature

Joseph Morans team found that pyruvate, glyoxylate, and ferrous iron can produce all but two (shown in black) molecules in the Krebs cycle.

For example, Moran has shown that iron can reduce carbon dioxide to form key metabolic intermediates of the reverse Krebs cycle and acetyl coenzyme A pathway, two ancient metabolic pathways that bacteria still use (Nat. Ecol. Evol. 2018, DOI: 10.1038/s41559-018-0542-2, and 2017, DOI: 10.1038/s41559-017-0311-7). His team has also found that pyruvate and glyoxylate can produce almost all components of the forward Krebs cycle in the presence of ferrous iron (Nature 2019, DOI: 10.1038/s41586-019-1151-1). I guess Ive made it a habit of trying to show that processes that we thought of as biotic can actually occur abiotically, he says.

And Moran is not the only one to argue that some biochemical reactions could have preceded life. A recent study from the Center for Chemical Evolution demonstrates how key analogs of the Krebs cycle can be produced under mild conditions without enzymes or metals (Nat. Chem. 2020, DOI: 10.1038/s41557-020-00560-7). Meanwhile, a team led by Bartosz Grzybowski, a physical organic chemist at South Koreas Institute for Basic Science, used computer algorithms to model how complex prebiotic chemical processes could have emerged from a handful of starting materials (Science 2020, DOI: 10.1126/science.aaw1955). Grzybowski previously developed software that uses chemical reaction rules to plan syntheses of complex organic molecules like pharmaceuticals. In this new study, his team taught a computer program rules based on possible prebiotic chemical reactions found in the literature and then watched what reactions it could plan starting with six simple molecules that probably existed on a prebiotic Earth. The researchers were excited when their software identified chemical cyclessynthetic routes that reproduce their starting materialsas you would expect from a rudimentary metabolism.

As chemists learn more about how chemical complexity can arise from simple mixtures of molecules, Moran and others say that astrobiologists will need to rethink what constitutes a biosignature or at least where metabolism fits on the Ladder of Life Detection.

The Laboratory for Agnostic Biosignatures (LAB) is a consortium of scientists funded by a grant from NASA to do just that. LAB is interested in looking at biosignatures that arent biased by Earths biochemistry.

Lee Cronin, a chemist with the University of Glasgow and a LAB researcher, thinks its more than likely that the chemistry that led to the existing biology on Earth is no longer evident in the biochemistry we see. This means it may be impossible to reverse engineer what prebiotic chemistry on early Earthor another planetmight have looked like solely from the life thats present today. As a result, a biosignature based on Earths current biochemistry may not help us spot signs of developing life somewhere else.

LAB is looking for agnostic biosignaturesphysical indicators that dont rely on an analogy to Earths biochemistrysuch as elemental accumulation. To understand the concept of elemental accumulation, for example, imagine an aerial view of a desert landscape peppered with sage brush, suggests NASAs Graham, LABs deputy principal investigator. The amount of carbon that has accumulated in the sage plants is significantly different from that of the surrounding landscape, indicating that some biotic processin this case, the plants growthis at work. This perspective even works down to the scale of microbes. If you think about it, thats kind of a rudimentary way of describing a cell: its a defined area where theres an accumulation and chemical abundance pattern that differs from its surrounding environment, she says. Looking for elemental accumulation patterns like these doesnt rely on an analogy to life on Earth, making it agnostic and possibly more broadly useful to astrobiologists.

Beyond Mars

Mars isnt the only extraterrestrial body where life might exist or might have once existed. Recently, our nearest planetary neighbor, Venus, intrigued astronomers when a research team led by Jane Greaves at Cardiff University reported the first signs of phosphine in the planets cloud decks (Nat. Astron. 2020, DOI: 10.1038/s41550-020-1174-4). This molecule is associated with anaerobic microbes on Earth, which had many astrobiologists excited for the possibility of alien life in the venusian atmosphere.

Phosphine could be a biosignature on Venus because it doesnt seem to belong. The planets atmosphere is highly oxidizingyet PH3 is a highly reduced molecule. In the Ladder of Life Detection, this gas is a possible feature of metabolism. New evidence suggests that the phosphine signal could be an artifact of data processing (arXiv 2020, arXiv: 2010.09761). The new study was published on a preprint server, meaning it has not yet been peer-reviewed. Even so, some critics wonder if there might be an abiotic explanation for phosphines presence on Venus.

What it [the phosphine signal] shows is something weird is going on on Venus, says Matthew Pasek, a geochemist with the University of South Florida who specializes in phosphorus chemistry. He thinks that the authors of the first paper may have been too quick to dismiss abiotic avenues for phosphine production on Venus. For example, not knowing the composition of Venuss rocky surface makes it hard to rule out the possibility that acid rain from the cloud decks volatilized phosphorus in the planets crust to produce phosphoric acid, which eventually formed phosphine. Theres just too much we dont know about Venuss geochemistry without sending missions to probe it directly, Pasek says.

Farther out in our solar system, astronomers have identified other celestial bodies that may host life. In 2026, NASA will launch a mission to Titan, an icy moon orbiting Saturn. Titan is one of the few planetary bodies in our solar system with a dense atmosphere composed of nitrogen gas and methane. Scientists are particularly intrigued by the aqueous ocean hidden below Titans icy crust. This carbon-rich sea occasionally explodes into the moons atmosphere through ice-spewing volcanoes, a process called cryovolcanism. Michael Malaska, a planetary scientist studying Titan at NASAs Jet Propulsion Laboratory (JPL), believes that the moons vast oceans and plentiful carbon make it one of the most likely places in the solar system to find life. But on an alien moon chock full of organic molecules, it will be challenging to distinguish biosignatures from complex molecules made through background carbon chemistry.

Malaska is part of a team at JPL led by planetary geologist Rosaly Lopes that is investigating how geochemical processes on the moon transport and alter carbon-based molecules. Lopes thinks the subsurface ocean is the most likely place for life to occur on Titan, so part of the teams mission is to understand what kinds of biosignatures might arise from the moons carbon-rich waters. Because of Titans complex geological processes, the researchers also have to consider how these biosignatures might be modified as they go through the ice crust and come out as either gases or part of cryolava, she says.

Sign up for C&EN's must-read weekly newsletter

The search for life beyond Earth also continues into the distant galaxy. Soon satellites like the James Webb Space Telescope will be able to study the habitability of exoplanets far outside our solar system.

What will scientists find inside or outside our solar system? Were more likely to find traces of a prebiotic system than a biological system on another planet, Westall says. She worries that we still dont know enough about the fundamentals of abiotic chemistry to suss out the in-between bits of a system with the potential to develop into biology.

Many scientists believe that given the right tools and enough time, we will find life beyond Earth. Others remain uncertain. Do I think its there? Yeah, probably, Graham says. Do I think well find it? Maybe.

The chase is half the battle, Malaska says. If we did all of this and we found out that there are no other places in the solar system that has life, that would have very huge implications. Wed have to consider how absolutely lucky we are to have had this accident happen to us.

The rest is here:
What are chemical signs of life beyond Earth? - Chemical & Engineering News

Researchers study the role of viral intramembrane interactions in controlling programmed cell death – News-Medical.net

A research group from the Department of Biochemistry and Molecular Biology of the University of Valencia (UV), in coordination with the National Centre for Biotechnology (CNB) of the CSIC, has studied the role of the interactions within the membrane of proteins of viral families Herpesviridae and Poxviridae in the control of programmed cell death. The work, published in Nature Communications, could have implications for the development of treatments for viral infection, as well as the prevention of cancers associated with them.

The results of the finding, led by Dr. Luis Martnez, Ph.D. in the Department of Biochemistry and Molecular Biology, would imply that interactions within the membrane between virus proteins and the host individual could be used as therapeutic targets for the treatment of some viral infections. An agent capable of blocking such interactions would not only reduce, or even inhibit, viral replication, but also slow down the possible development of cancer associated with such infections.

Cell apoptosis (programmed cell death) is an essential process in multicellular organisms, as it contributes to the balance between cell death, proliferation and differentiation, which is relevant for the development and proper functioning of living things. This makes it a highly regulated process involving many components, including the protein family known as Bcl2 (B-cell lymphoma 2).

In order to maximize their growth, viruses in the Herpesviridae and Poxviridae families have developed mechanisms to modulate cell death in host individuals. Therefore, these viruses have proteins structurally similar to Bcl2 proteins, known as viral Bcl2, which have a transmembrane domain that allows the protein to be inserted into the target membrane to deregulate cell apoptosis.

In this study we show that viral Bcl2 proteins have a transmembrane domain (TMD) that allows them to be anchored to the mitochondrial membrane. In addition, we observed that these proteins are able to interact with each other and with other Bcl2 proteins of host individuals through this domain. Our results also indicate that these interactions are key to controlling cell death after an apoptotic stimulus such as a viral infection."

Dr. Luis Martnez, Ph.D., Department of Biochemistry and Molecular Biology

Source:

Journal reference:

Garca-Murria, A.J., et al. (2020) Viral Bcl2stransmembrane domain interact with host Bcl2 proteins to control cellular apoptosis. Nature. doi.org/10.1038/s41467-020-19881-9.

Read the original here:
Researchers study the role of viral intramembrane interactions in controlling programmed cell death - News-Medical.net

How Neuroscience Is Changing The Way Your Brain Processes Fear At Work – Forbes

Neuroscientists are studying how to keep your brain from freaking out on the job.

When a frightful creature startles you, your brain may activate its fear-processing circuitry, sending your heart racing to help you escape the threat. Imagine, for example, youre weeding your garden and see a coiled water hose, but you think its a snake. The job of your brains fear-processing circuits is to help you learn from experience to recognize which situations are truly dangerous and to respond appropriately. So if the scare comes from a water hose instead of a snake, youll probably recover quickly. In more dire circumstances, however, if the coiled object is a poisonous copperhead, the brains fear response can be critical for your survival. Being able to fear is the ability to sense the danger and is the driving force to figure out a way to escape or fight back, said Cold Spring Harbor Laboratory ProfessorBo Li.

Neuroscientists know that fear memories are made in the amygdalaan almond-shaped structure deep in the brain, considered the hub for fear processing. And thats where many of their studies begin. Lis team is probing the brain circuits that underlie fear, using sophisticated neuroscience tools to map their connections and tease out how specific components contribute to learning fear. An understanding of these circuits could lead to better ways to control the overactive or inappropriate fear responses experienced by employees with anxiety disorders and those who suffer from panic attacks and post traumatic stress disorder in the workplace.

Suppose, for example, your boss walks by your desk. You hook eye contact with her, smile, and nod. She looks straight at you, but doesnt acknowledge your presence. She might as well be staring at the wall. Holy cow, you say to yourself. I must be in hot water. You shrink inside, ruminating over what you might have done to deserve this. Your heart races, and you feel shaky. Its just a few days before your performance review. Sleepless nights stalk you. You toss and turn as your brain circuits spin with worry over job security. This is your amygdala in action, making up a story from its library to help you survive.

The day of your evaluation, your boss calls you into her office, and your stomach flip-flops. You tremble the way you did in sixth grade when you were summoned into the principals office. But, to your dismay, she greets you with a smile and gives you a glowing performance evaluation. Not only are you not in hot water, she calls you a highly valued team member, a laudable successthe exact opposite of what your anxiety predicted and a feather in your career cap.

All that worry and rumination for nothing. But it has already taken a toll on your mind and body and your job performance. Studies show that 90% of the worries that our brain circuits scare us with are false alarms that never manifest. Still, the amygdala catalogues, prioritizes and remembers the negative experiences in an attempt to prevent lifes unexpected curve balls from ambushing you. If youre like most people, you believe the library of memories from the past as they show up in the present moment.

But had you thought about it (been able to keep your prefrontal cortex or rational brain online) you might have realized there are a number of benign reasons your boss didnt acknowledge you when she walked by your desk. Perhaps she was distracted by her own worries, deep in thought over an upcoming meeting or simply just didnt see you. But our brain circuits in the amygdala jump into action, focused only on the disastrous possibilities, blowing your thoughts out of proportion sending you into spirals of rumination. And you fell for it hook, line and sinker just like all of us do.

While the amygdala was once thought to be devoted exclusively to processing fear, researchers now are broadening their understanding of its role. New research out of Stanford University shows that the fear circuit extends far beyond the amygdala. Lis team has found that the amygdala is also important for reward-based learning, and as they trace its connections to other parts of the brain, they are uncovering additional complexity. It is important for formation of fearful memory, but its also important for interacting with other brain systems in a different behavior context, Li said. We think that this circuit that we discovered that plays a role in regulating fearful memory is only a tip of the iceberg. It is indeed important for regulating fearful memory, but probably is also involved in more complex behavior.

Li and his colleagues were surprised recently to find that the amygdala communicates with a part of the brain best known for its role in controlling movement. The structure, called the globus pallidus, was not known to be involved in fear processing or memory formation. But when the researcher team interfered with signaling between the amygdala and the globus pallidus in the brains of mice, they found that the animals failed to learn that a particular sound cue signaled an unpleasant sensation. Based on their experiments, this component of the fear-processing circuitry might be important for alerting the brain which situations are worth learning from, Li said.

The implications for employees with anxiety disorders or just plain harried workers are that they can worry less and focus more on their jobs, which could potentially escalate engagement, job performance and career success. Not to mention the companys bottom line.

The rest is here:
How Neuroscience Is Changing The Way Your Brain Processes Fear At Work - Forbes

Learning Science, Institutional Change and ‘The Idea of the Brain’ | Learning Innovation – Inside Higher Ed

The Idea of the Brain: The Past and Future of Neuroscience by Matthew Cobb

Published in April of 2020.

There is this idea that I have. An idea that I expect will occupy most of the rest of my academic career. That idea has to do with the future of higher education, and it goes something like this:

Universities change by moving their institutional structures in ever-greater alignment with learning science.

That's it.

Institutional structures cover everything from incentives to policies to investments to organizational arrangements. Policies around hiring, tenure, and promotion (or adjunct recruiting) and decisions about which building to build (or not build) all fall within the umbrella of institutional structure.

We create and recreate our universities. Their designs and operations are not divinely decreed. We make them. And if we choose, we can make our universities operate in a way that aligns (or not) to what we are learning about how people learn.

Surely other things matter than learning science in determining the future of the university. Of course. Everything matters, from demographics to public policy to technological advancements. A theory of university change that puts learning science at its heart does not need to ignore all of these forces. This theory predicts that they will play out at an institutional level in a way that is mediated by advances in learning science.

This big idea about how universities will change - if it is a big idea - brings us to The Idea of the Brain. If we are going to put learning science at the core of a theory that attempts to predict the future of the university, we need to recognize that we are thinking about the brain. The brain, after all, is where learning happens.

The Idea of the Brain is one part intellectual history, one part an overview of neuroscience. It is helpful to ground contemporary understandings of how the brain works in centuries of thinking about its structures and function. Throughout history, humans have used different metaphors to understand the workings of the brain. These stories have progressed from the brain as analogous to a machine, to plumbing, to electrical wiring, to a telegraph, and more recently to a computer. As we know today, none of these metaphors is very accurate, and the comparison of the brain with a computer has likely set-back popular understanding of brain function.

What comes across most strongly in The Idea of the Brain is how little we still understand its workings. Cobb, a professor of biological sciences, believes we are decades if not centuries away from human-brain like artificial intelligence. Consciousness remains as much a mystery today as at the birth of the modern field of neuroscience in the 1950s. We've made astounding advances in areas such as brain imaging, yet we seem to be no closer to a theory of the brain that would allow us to replicate its functioning in silicon or software.

That we still understand so little about how the brain's physical structures evolved to create conscious thought should not dissuade us from the goal of advancing the science of learning. We may not understand the brain well enough to create true artificial intelligence, but we know a great deal about how the brain learns.

If our goal is to align our universities with learning science, one place to start is to situate the study of the brain as a foundational element of a liberal education. A cross-discipline reading of The Idea of the Brain seems like an excellent place to start.

What are you reading?

The rest is here:
Learning Science, Institutional Change and 'The Idea of the Brain' | Learning Innovation - Inside Higher Ed

Neuroscience Antibodies and Assays Market Research Report 2020: Market Competition Trend and Price by Manufacturers till 2026 – Cheshire Media

The Neuroscience Antibodies and Assays Market grew in 2019, as compared to 2018, according to our report, Neuroscience Antibodies and Assays Market is likely to have subdued growth in 2020 due to weak demand on account of reduced industry spending post Covid-19 outbreak. Further, Neuroscience Antibodies and Assays Market will begin picking up momentum gradually from 2021 onwards and grow at a healthy CAGR between 2021-2025

Deep analysis about market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically. This report will help you to establish comprehensive overview of the Neuroscience Antibodies and Assays Market

Get a Sample Copy of the Report at: https://i2iresearch.com/report/global-neuroscience-antibodies-and-assays-market-2020-market-size-share-growth-trends-forecast-2025/#download-sample

The Neuroscience Antibodies and Assays Market is analysed based on product types, major applications and key players

Key product type:ConsumablesInstruments

Key applications:Pharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesHospitals & Diagnostic Centers

Key players or companies covered are:Thermo FisherAbcamBio-RadMerckCell Signaling TechnologyGenscriptRockland ImmunochemicalsBioLegendSanta Cruz BiotechnologyRocheSiemens

The report provides analysis & data at a regional level (North America, Europe, Asia Pacific, Middle East & Africa , Rest of the world) & Country level (13 key countries The U.S, Canada, Germany, France, UK, Italy, China, Japan, India, Middle East, Africa, South America)

Inquire or share your questions, if any: https://i2iresearch.com/report/global-neuroscience-antibodies-and-assays-market-2020-market-size-share-growth-trends-forecast-2025/

Key questions answered in the report:1. What is the current size of the Neuroscience Antibodies and Assays Market, at a global, regional & country level?2. How is the market segmented, who are the key end user segments?3. What are the key drivers, challenges & trends that is likely to impact businesses in the Neuroscience Antibodies and Assays Market?4. What is the likely market forecast & how will be Neuroscience Antibodies and Assays Market impacted?5. What is the competitive landscape, who are the key players?6. What are some of the recent M&A, PE / VC deals that have happened in the Neuroscience Antibodies and Assays Market?

The report also analysis the impact of COVID 19 based on a scenario-based modelling. This provides a clear view of how has COVID impacted the growth cycle & when is the likely recovery of the industry is expected to pre-covid levels.

Contact us:i2iResearch info to intelligenceLocational Office: *India, *United States, *GermanyEmail: [emailprotected]Toll-free: +1-800-419-8865 | Phone: +91 98801 53667

Read the original post:
Neuroscience Antibodies and Assays Market Research Report 2020: Market Competition Trend and Price by Manufacturers till 2026 - Cheshire Media

Tag: Neuroscience antibodies and assays Market – The Market Feed

Neuroscience antibodies and assays Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

The data presented in the global Neuroscience antibodies and assays market report is a compilation of data identified and collected from various sources. The scope of growth of the Neuroscience antibodies and assays market during the forecast period is identified after analyzing different data sources. The report is a valuable guidance tool that can be used to increase the market share or to develop new products that can revolutionize the market growth.

Get Sample Copy of This Report: https://www.premiummarketinsights.com/sample/BRC00017587

The analysis of the collected data also helps in providing an overview of the Neuroscience antibodies and assays industry which further helps people make an informed choice. Latent growth factors that can manifest themselves during the forecast period are identified as they are key to the Neuroscience antibodies and assays market growth. The Neuroscience antibodies and assays report presents the data from the year 2020 to the year 2027 during the base period while forecasting the same during the forecast period for the year 2020 to the year 2027.

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in This Report:

Thermo Fisher Scientific, Abcam, Bio-Rad, Merck KGAA, Cell Signaling Technology, Genscript, Rockland Immunochemicals. Bio Legend, Santa Cruz Biotechnology, Tecan, F. Hoffmann-La Roche, Siemens.

To inquire about the discount available on this Report, visit @ https://www.premiummarketinsights.com/discount/BRC00017587

Global Neuroscience antibodies and assays Market by Geography:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)Europe (Turkey, Germany, Russia UK, Italy, France, etc.)North America (the United States, Mexico, and Canada.)South America (Brazil etc.)The Middle East and Africa (GCC Countries and Egypt.)

This analysis provides evaluation for altering competitive dynamics:

This thorough Neuroscience antibodies and assays analysis of this shifting contest dynamics and keeps you in front of competitions; Six-year prediction assessment primarily based mostly on the way the sector is anticipated to development; Precisely which Neuroscience antibodies and assays application/end-user kind or Types can observe incremental increase prospects; Which trends, barriers, and challenges could impact the development and size of Neuroscience antibodies and assays economy; It helps to know that the vital product-type sections along with their growth;

Fundamentals of Table of Content:

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered1.4 Market Analysis by Type1.5 Market by Application1.6 Study Objectives1.7 Years Considered

2 Global Growth Trends2.1 Neuroscience antibodies and assays Market Size2.2 Neuroscience antibodies and assays Growth Trends by Regions2.3 Industry Trends

3 Market Share by Key Players3.1 Neuroscience antibodies and assays Market Size by Manufacturers3.2 Neuroscience antibodies and assays Key Players Head office and Area Served3.3 Key Players Neuroscience antibodies and assays Product/Solution/Service3.4 Date of Enter into Neuroscience antibodies and assays Market3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product4.1 Global Neuroscience antibodies and assays Sales by Product4.2 Global Neuroscience antibodies and assays Revenue by Product4.3 Neuroscience antibodies and assays Price by Product

5 Breakdown Data by End User5.1 Overview5.2 Global Neuroscience antibodies and assays Breakdown Data by End User

Original post:
Tag: Neuroscience antibodies and assays Market - The Market Feed